AI Analytics Improves Patient Matching for Cancer Research

Client Success

Health-tech leader increases patient matching accuracy for advanced cancer research with AI-powered analytics

The client is a US-headquartered, global leader in medical technology, pharmaceutical diagnostics, and digital solutions innovator. It enables healthcare professionals to make faster and more informed decisions through intelligent devices, data, analytics, applications, and services.

The Challenge

The client was keen to enhance their Imaging AI platform to enable clinical researchers accurately identify patients that are most likely to respond positively to new therapies. The client’s current solutions based on a single imaging modality were not robust and efficient enough to accurately profile diseases as per types and stages. To achieve these, they needed an experienced technology partner to assist them in integrating and processing multi-omics and radiology data.

The Solution

The healthcare technology provider collaborated with Persistent for our proven track record of digitally transforming other organizations in this domain.

Persistent considered genomics, radiomics, and clinical data for non-small cell lung cancer (NSCLC) available from a public repository, to build training models on individual and various data sources. It was also a critical step in predicting the recurrence and progression of the disease. The idea was to enable accurate prediction for better and personalized patient care.

As part of the solution, Persistent developed a new AI-powered analytics and workflow solution to help the client serve both clinical and biopharma markets. It comprised a HIPPA-compliant SaaS analytics platform built on AWS. Plus, necessary steps were taken to create a data ingestion pipeline to integrate and harmonize data from Electronic Health Records, Radiology Information Systems, imaging, and sequencing instruments, and an integrated multimodal data processing pipeline.

The Outcome

The client has experienced a 2X boost in its efficiency and accuracy in analyzing data from multiple modalities. It has allowed them to identify patients who are fit to receive new therapies with utmost precision. Additionally, the longitudinal patient data visualization portal assists the client in tracking disease progression to offer personalized care.

Contact us

(*) Asterisk denotes mandatory fields

    You can also email us directly at info@persistent.com

    You can also email us directly at info@persistent.com